Renal Insufficiency and Mortality in Coronary Artery Disease with Reduced Ejection Fraction
Yong Peng,Tian-Li Xia,Wei Liu,Bao-Tao Huang,Zhen-Gang Zhao,Fang-Yang Huang,Chen Zhang,Yan-Biao Liao,Hua Chai,Xiao-Lin Luo,Qiao Li,Yuan-Ning Xu,Chi Chen,Qing-Tao Meng,Mao Chen,De-Jia Huang
DOI: https://doi.org/10.1016/j.ejim.2016.01.002
IF: 7.749
2016-01-01
European Journal of Internal Medicine
Abstract:Background: Despite strong evidence linking decreased estimated glomerular filtration rate (eGFR) to worse cardiovascular outcome, the impact of eGFR onmortality in coronary artery disease (CAD) patientswith different left ventricular ejection fraction (EF) is not well defined.Methods: A retrospective cohort study. From Jul. 2008 to Jan. 2012, consecutive patients with CAD ofWest China Hospitalwere enrolled andwere grouped into 3 eGFR categories: = 90, 60-90, and b60 mL/min/1.73m2. Patients with EF = 50% or b50% were defined as preserved EF or reduced EF, respectively. The endpoints were all-cause mortality and cardiac mortality.Results: There are 2161 patients according to the inclusion criteria and follow-up requirement. The mean follow-up time was 30.97 +/- 11.70 months. Cumulative survival curves showed that in patients with reduced EF, renal insufficiency significantly increases all-cause mortality and cardiovascular mortality in a graded fashion (mortality rate, moderate or severe vs. normal: 29.3% vs. 5.4%, p b 0.001; cardiacmortality rate, moderate or severe vs. normal: 18.2% vs. 4.5%, p= 0.001, respectively). Cox regression analysis showed that in CAD patientswith reduced EF, moderate to severe renal insufficiency increased all-cause mortality by 6.10-fold (HR 6.10, 95% CI 2.50 to 14.87) and cardiacmortality by 4.10-fold (HR 4.10, 95% CI 1.51 to 11.13). Use of beta-blockers, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), and statins was associated with decreased risk of mortality, but the use was lower in renal insufficiency patients, especially in combination of reduced EF.Conclusion: This study has found that the effect of renal function on prognosis in patientswith CAD is closely related to cardiac function. In patientswith reduced EF, renal insufficiency accompanies the higher risks of all-cause mortality and cardiovascular mortality. A higher number of treatments from beta-blocker, ACEIs or ARBs, and statin therapy were associated with decreased risk of mortality, even in the combination of renal insufficiency or declining cardiac function. (C) 2016 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.